Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 20,088 |
|
|||||
| News | - | ||||||
| Day High | 11.97 | Low High |
|||||
| Day Low | 11.29 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| PepGen Inc | PEPG | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.11 | 0.94% | 11.83 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 11.70 | 11.29 | 11.97 | 11.83 | 11.72 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 551 | 20,088 | $ 11.70 | $ 234,970 | - | 3.72 - 17.51 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:02:02 | priorref | 185 | $ 11.83 | USD |
PepGen Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 378.55M | 32.35M | - | 0 | -78.63M | -2.43 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
PepGen News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PEPG Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.61 | 12.61 | 10.215 | 11.19 | 65,965 | -0.78 | -6.19% |
| 1 Month | 13.17 | 15.34 | 10.215 | 12.31 | 56,873 | -1.34 | -10.17% |
| 3 Months | 10.36 | 17.51 | 10.03 | 13.74 | 121,768 | 1.47 | 14.19% |
| 6 Months | 5.38 | 17.51 | 3.72 | 10.78 | 100,752 | 6.45 | 119.89% |
| 1 Year | 12.70 | 17.51 | 3.72 | 10.17 | 77,907 | -0.87 | -6.85% |
| 3 Years | 15.60 | 20.00 | 3.72 | 11.19 | 105,157 | -3.77 | -24.17% |
| 5 Years | 15.60 | 20.00 | 3.72 | 11.19 | 105,157 | -3.77 | -24.17% |
PepGen Description
| PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. |
